CAS: 1163719-56-9
Ref: AN-AG0096DJ
| 5mg | 151.00 € | |
| 10mg | 180.00 € | |
| 25mg | 503.00 € | |
| 50mg | 627.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
CCT196969
CAS:1163719-56-9
CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, …
Formula:
C27H24FN7O3
Purity:
99.65%
Color and Shape:
Solid
Molecular weight:
513.52
- Inhibitors
- Angiogenesis
- MAPK
- Raf
- See more categories
- Tyrosine Kinase/Adaptors
- Src
Ref: TM-T4133
| 2mg | 48.00 € | |
| 5mg | 72.00 € | |
| 10mg | 97.00 € | |
| 25mg | 184.00 € | |
| 50mg | 324.00 € | |
| 100mg | 485.00 € | |
| 1ml*10 (DMSO) | 76.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: 54-BISN0303
| 1mg | 84.00 € | |
| 5mg | 134.00 € | |
| 10mg | 194.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: TR-C227940
| 1g | 10,915.00 € |
Estimated delivery in United States, on Wednesday 12 Jun 2024
Cct196969
CAS:1163719-56-9
CCT196969 is a drug candidate that has been shown to have anti-cancer properties. It has …
Formula:
C27H24FN7O3
Purity:
Min. 95%
Molecular weight:
513.52 g/mol
Ref: 3D-NWB71956
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024
